Literature DB >> 22743282

Comparison of plasma concentrations of soluble ST2 measured by three different commercially available assays: the MBL ST2 assay, the Presage ST2 assay, and the R&D ST2 assay.

Thomas Mueller, Matthias Zimmermann, Benjamin Dieplinger, Hendrik Jan Ankersmit, Meinhard Haltmayer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22743282     DOI： 10.1016/j.cca.2012.06.021

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


× No keyword cloud information.
  8 in total

1.  Serendipity and technical considerations for the measurement of serum heat shock protein HSP27 in patients with COPD and lung cancer.

Authors:  Hendrik Jan Ankersmit; Christopher Lambers; Matthias Zimmermann; Stefan Hacker; Bernhard Moser
Journal:  Cell Stress Chaperones       Date:  2015-08-04       Impact factor: 3.667

2.  Evaluation of new and old biomarkers in dogs with degenerative mitral valve disease.

Authors:  Stephanie Klein; Ingo Nolte; José Luis Granados-Soler; Philipp Lietz; Maximiliane Sehn; Jonathan Friedemann Raue; Karl Rohn; Eva-Maria Packeiser; Jan-Peter Bach
Journal:  BMC Vet Res       Date:  2022-07-02       Impact factor: 2.792

Review 3.  Interleukin-33 in Systemic Sclerosis: Expression and Pathogenesis.

Authors:  Liya Li; Honglin Zhu; Xiaoxia Zuo
Journal:  Front Immunol       Date:  2018-11-15       Impact factor: 7.561

4.  Short-term and long-term prognostic value of circulating soluble suppression of tumorigenicity-2 concentration in acute coronary syndrome: a meta-analysis.

Authors:  Linlin Gu; Jing Li
Journal:  Biosci Rep       Date:  2019-06-04       Impact factor: 3.840

5.  Soluble ST2 and Galectin-3: What We Know and Don't Know Analytically.

Authors:  Thomas Mueller; Benjamin Dieplinger
Journal:  EJIFCC       Date:  2016-08-01

6.  ST2 and Galectin-3: Ready for Prime Time?

Authors:  Wouter C Meijers; A Rogier van der Velde; Rudolf A de Boer
Journal:  EJIFCC       Date:  2016-08-01

7.  Compelling Benefit of Soluble Suppression of Tumorigenicity-2 in Post-Myocardial Infarction Estimation of Risk: The Time Is Right for Its Routine Use in the Clinic.

Authors:  Javier Díez; Antoni Bayes-Genis
Journal:  J Am Heart Assoc       Date:  2017-10-20       Impact factor: 5.501

8.  Prospective diagnostic accuracy study of plasma soluble ST2 for diagnosis of acute aortic syndromes.

Authors:  Fulvio Morello; Alice Bartalucci; Marco Bironzo; Marco Santoro; Emanuele Pivetta; Alice Ianniello; Francesca Rumbolo; Giulio Mengozzi; Enrico Lupia
Journal:  Sci Rep       Date:  2020-02-20       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.